首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Impaired innate immune alveolar macrophage response and the predilection for copd exacerbations
【24h】

Impaired innate immune alveolar macrophage response and the predilection for copd exacerbations

机译:先天性免疫肺泡巨噬细胞反应受损,并易患COPD急性发作

获取原文
获取原文并翻译 | 示例
           

摘要

Background Alveolar macrophages (AM) in COPD have fundamentally impaired responsiveness to Toll-like receptor 2 (TLR2) and TLR4 ligands of non-typeable Haemophilus influenzae (NTHI). However, the contribution of innate immune dysfunction to exacerbations of COPD is unexplored. We hypothesised that impaired innate AM responses in COPD extend beyond NTHI to other pathogens and are linked with COPD exacerbations and severity. Methods AMs, obtained by bronchoalveolar lavage from 88 volunteers with stable-to-moderate COPD, were incubated with respiratory pathogens (NTHI, Moraxella catarrhalis (MC), Streptococcus pneumoniae (SP) and TLR ligands lipopolysaccharide, Pam3Cys) and elicited IL- 8 and TNF-a were measured by microsphere flow cytometry. NF-B nuclear translocation was measured by colorimetric assay. AM TLR2 and TLR4 expression was determined by immunolabeling and quantitation of mean fluorescent indices. Participants were monitored prospectively for occurrence of COPD exacerbations for 1 year following bronchoscopy. Non-parametric analyses were used to compare exacerbation-prone and nonexacerbation- prone individuals. Results 29 subjects had at least one exacerbation in the follow-up period (exacerbation-prone) and 59 remained exacerbation-free (non-exacerbation-prone). AMs of exacerbation-prone COPD donors were more refractory to cytokine induction by NTHI ( p=0.02), MC (p=0.045) and SP ( p=0.046), and to TLR2 (p=0.07) and TLR4 ( p=0.028) ligands, and had diminished NF-B nuclear activation, compared with non-exacerbationprone counterparts. AMs of exacerbation-prone subjects were more refractory to TLR2 upregulation by MC and SP (p=0.04 each). Conclusions Our results support a paradigm of impaired innate responses of COPD AMs to respiratory pathogens, mediated by impaired TLR responses, underlying a propensity for exacerbations in COPD.
机译:背景COPD中的肺泡巨噬细胞(AM)从根本上削弱了对不可分型流感嗜血杆菌(NTHI)的Toll样受体2(TLR2)和TLR4配体的响应能力。然而,尚未发现先天性免疫功能障碍对COPD病情加重的影响。我们假设,COPD中固有的AM反应受损会超出NTHI范围,延伸至其他病原体,并与COPD恶化和严重程度相关。方法将88例稳定至中度COPD志愿者通过支气管肺泡灌洗获得的AMs与呼吸道病原体(NTHI,卡他莫拉菌(MC),肺炎链球菌(SP)和TLR配体脂多糖,Pam3Cys)孵育并诱导IL-8和通过微球流式细胞术测量TNF-α。 NF-B核易位是通过比色法测定的。通过免疫标记和定量平均荧光指数确定AM TLR2和TLR4表达。支气管镜检查后1年内对参与者进行COPD急性发作的前瞻性监测。使用非参数分析来比较易发作和不易发作的个体。结果29名受试者在随访期内至少有一次加重(倾向加重),而59例未加重(不加重)。易于发作的COPD供体的AMs对NTHI(p = 0.02),MC(p = 0.045)和SP(p = 0.046),TLR2(p = 0.07)和TLR4(p = 0.028)诱导的细胞因子更难治。配体,并减少了NF-B核活化,与不加重的对应物相比。容易发作的受试者的AMs对MC和SP对TLR2上调的耐受性更高(每个p = 0.04)。结论我们的结果支持了一种由TPD反应减弱介导的COPD AM对呼吸道病原体的先天反应减弱的范例,表明COPD恶化的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号